Yang Liu

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsPharmacogenomicsNeurology and neuromuscular diseasesBiomaterialsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 08, 2026
Targeting of CH25H to boost p62-dependent autophagic degradation of α-synuclein in cell and mouse models of Parkinson's disease.

|May 22, 2026
Neuroprotective effect of astrocytic dopamine Drd2 receptor on mitochondrial complex I in a mouse model of Parkinson's disease through β-arrestin2-NDUFA10 regulation.

|Feb 04, 2026
APP-C31 pathology as a target in neurodegenerative diseases.

King Chi Yip, Woon Fei Ho, Yang Liu

|Aug 28, 2025
Navigating Brain Organoid Maturation: From Benchmarking Frameworks to Multimodal Bioengineering Strategies.

Jingxiu Huang, Yingli Zhu, Jiong Tang

|Oct 28, 2023
A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer.

Xiao-Dan Lyu, Yang Liu, Jia Wang

|Aug 25, 2023
Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury.

Si-Yuan Jiang, Tian Tian, Wen-Jie Li

Pageof 1

Frequent Collaborators

2 joint publications

Renhong Du

2 joint publications

Ming Lu

1 joint publications

Jingxiu Huang

1 joint publications

Yingli Zhu